下腔静脉滤器放置位置对器械并发症的影响
该回顾性研究分析了2008至2016年单中心1497例下腔静脉滤器置入患者,按滤器尖端相对下位肾静脉的位置分为三组,比较长期器械并发症。结果显示滤器放置位置未影响器械并发症发生,下腔静脉血栓形成组间无统计学显著差异。
要点
- 下腔静脉滤器放置位置分为肾静脉水平或以上、下1-20mm、下>20mm三组。
- 下腔静脉血栓形成组A 1.5%、组B 1.8%、组C 2.5%,差异无统计学显著(P=.638)。
- 平均随访2.6±2.3年,全因死亡率41.3%,组间差异无统计学显著(P=.051)。
核心结论
- 下腔静脉滤器短期和长期并发症发生率低,包括下腔静脉血栓形成。
- 在本研究中,滤器放置位置未影响器械并发症的发生。
研究设计与样本
- 回顾性研究,纳入2008至2016年单中心接受下腔静脉滤器置入的患者。
- 根据滤器尖端相对下位肾静脉的位置分为三组:肾静脉水平或以上(组A)、下1至20mm(组B)、下>20mm(组C)。
- 主要终点为下腔静脉血栓形成和器械相关死亡。
主要发现
- 组B为最常见放置位置(64.0%)。
- 平均年龄组C最低,组A次之,组B最高(分别为59.5岁、64.6岁、62.2岁;P=.003)。
- 组C最常经颈静脉入路(组C 71.7%、组A 48.3%、组B 62.4%;P<.001),且第一代滤器使用更多(组C 58.5%、组A 46.6%、组B 52.5%;P=.045)。
- 下腔静脉血栓形成组A 1.5%、组B 1.8%、组C 2.5%,差异无统计学显著(P=.638);症状性滤器穿透、移位和断裂分别仅1例、1例和3例;无器械相关死亡。
- 平均随访2.6±2.3年,全因死亡率41.3%,组间差异无统计学显著(P=.051);多因素logistic回归显示放置位置不能预测短期或长期深静脉血栓、肺栓塞、下腔静脉血栓或全因死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Indwelling inferior vena cava (IVC) filters can cause complications, including penetration into surrounding structures, migration, and thrombosis of the vena cava. Computational fluid dynamics suggests juxtarenal placement of IVC filters decreases the risk of thrombosis; however, this has not been explored clinically. The present study examines the effect of filter placement position on long-term device complications with an emphasis on IVC thrombosis. We hypothesized that IVC filters placed further caudal to the renal veins were more likely to develop long-term thrombosis. METHODS: A retrospective review of the medical records of patients receiving IVC filters at a single tertiary center between 2008 and 2016 was performed. Patients missing follow-up or procedural imaging data were excluded. The placement procedure venograms were reviewed, and the distance from the filter apex to the more inferior renal vein was measured using reported IVC filter lengths for calibration. The patients were divided into three groups according to the tip position relative to the more inferior renal vein: at or superior (group A), 1 to 20 mm inferior (group B), and >20 mm inferior (group C). The patient and procedural characteristics and outcomes were compared between the three groups. The primary end points were IVC thrombosis and device-related mortality. RESULTS: Of 1497 eligible patients, 267 (17.8%) were excluded. The most common placement position was group B (64.0%). The mean age was lowest in group C, followed by groups A and B (age, 59.5 years, 64.6 years, and 62.2 years, respectively; P = .003). No statistically significant differences were found in the distribution of sex or the measured comorbidities. Group C was the most likely to receive jugular access (group C, 71.7%; group A, 48.3%; group B, 62.4%; P < .001) and received more first-generation filters (group C, 58.5%; group A, 46.6%; group B, 52.5%; P = .045). The short-term (<30-day) and long-term (≥30-day) outcomes, including access site hematoma, deep vein thrombosis, and pulmonary embolism, were uncommon, with no differences between the groups. Cases of symptomatic filter penetration, migration, and fracture were rare (one, one, and three cases, respectively). Although a pattern of increasing thrombosis with more inferior placement was found, the difference between groups was not statistically significant (group A, 1.5%; group B, 1.8%; group C, 2.5%; P = .638). No cases of device-related mortality occurred. All-cause mortality after a mean follow-up of 2.6 ± 2.3 years was 41.3% and did not vary significantly between the groups (P = .051). Multivariate logistic regression revealed that placement position did not predict for short- or long-term deep vein thrombosis, pulmonary embolism, IVC thrombosis, or all-cause mortality after adjustment for the baseline patient characteristics. CONCLUSIONS: IVC filters have low rates of short- and long-term complications, including IVC thrombosis. The placement position did not affect the occurrence of device complications in this study.
引用
- Grubman S, Kostiuk V, Brahmandam A, et al. Effect of inferior vena cava filter placement position on device complications. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 37356713. doi:10.1016/j.jvsv.2023.05.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。